Sanofi India Ltd Q1CY25 net profit at Rs. 119.5 crores

Sanofi India Limited has reported Standalone financial results for the period ended March 31, 2025.

Financial Results (Q1 CY2025) - QoQ Comparison

The company has reported total income of Rs. 539.2 crores during the period ended March 31, 2025 as compared to Rs. 520.8 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 119.5 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 91.3 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 51.89 for the period ended March 31, 2025 as compared to Rs. 39.64 for the period ended December 31, 2024.

Financials	Q1 CY2025	Q4 CY2024	% Change
Total Income	₹539.2 crs	₹520.8 crs	3.53%
Net Profit	₹119.5 crs	₹91.3 crs	30.89%
EPS	₹51.89	₹39.64	30.90%

Financial Results (Q1 CY2025) - YoY Comparison

The company has reported total income of Rs.539.2 crores during the period ended March 31, 2025 as compared to Rs.514.3 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.119.5 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.136.6 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.51.89 for the period ended March 31, 2025 as compared to Rs.59.31 for the period ended March 31, 2024.

Financials	Q1 CY2025	Q1 CY2024	% Change
Total Income	₹539.2 crs	₹514.3 crs	4.84%
Net Profit	₹119.5 crs	₹136.6 crs	-12.52%
EPS	₹51.89	₹59.31	-12.51%

Shares of Sanofi India Limited was last trading in BSE at Rs. 6042.35 as compared to the previous close of Rs. 5928.60. The total number of shares traded during the day was 325 in over 84 trades.

The stock hit an intraday high of Rs. 6070.00 and intraday low of 5950.05. The net turnover during the day was Rs. 1956131.00.

Source : Equity Bulls

Keywords

SanofiIndia Q1CY25 Q1CY2025 ResultUpdate